Basis: Trailing twelve months (TTM), to the latest fiscal quarter end. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on invested capital (ROIC) high or low?
The return on invested capital (ROIC) of -83.74% is 58% above its 5-year average of -200.96%, near the high end of its 5-year range (-835.63%–-83.74%).
As of the fiscal period ended Tuesday, June 30, 2026. 45.62% above its 12-month average of -154.01%.
Trailing-twelve-month return on invested capital at each fiscal quarter end; no daily interpolation. Q2 FY2026 (2026-06-30): -83.74%.
RETURN ON INVESTED CAPITAL (ROIC)
-83.74%
RETURN ON INVESTED CAPITAL (ROIC) AVG TTM
-154.01%
RETURN ON INVESTED CAPITAL (ROIC) AVG 3Y
-328.86%
RETURN ON INVESTED CAPITAL (ROIC) AVG 5Y
-200.96%
RETURN ON INVESTED CAPITAL (ROIC) AVG 10Y
N/A
RETURN ON INVESTED CAPITAL (ROIC) AVG 15Y
N/A
RETURN ON INVESTED CAPITAL (ROIC) AVG 20Y
N/A
CURRENT VS TTM AVG
+45.62%
CURRENT VS 3Y AVG
+74.54%
CURRENT VS 5Y AVG
+58.33%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-33.61%
median of 660 covered companies
CURRENT VS SECTOR MEDIAN
-149.13%
vs the sector median at left
Cingulate Inc.
Market Cap
$65.86M
Return on Invested Capital (ROIC)
-83.74%
TTM Avg
-154.01%
3Y Avg
-328.86%
5Y Avg
-200.96%
Market Cap
$66.42M
Return on Invested Capital (ROIC)
N/A
TTM Avg
-86.10%
3Y Avg
-83.22%
5Y Avg
-74.34%
Market Cap
$63.79M
Return on Invested Capital (ROIC)
-6.79%
TTM Avg
-4.87%
3Y Avg
-47.70%
5Y Avg
-62.00%
Market Cap
$63.78M
Return on Invested Capital (ROIC)
-56.22%
TTM Avg
-67.31%
3Y Avg
-52.91%
5Y Avg
-45.67%
Market Cap
$63.23M
Return on Invested Capital (ROIC)
N/A
TTM Avg
-165.22%
3Y Avg
-160.52%
5Y Avg
-107.11%
Market Cap
$63.30M
Return on Invested Capital (ROIC)
-52.40%
TTM Avg
-44.92%
3Y Avg
-44.92%
5Y Avg
-44.02%
Market Cap
$63.14M
Return on Invested Capital (ROIC)
-4.72%
TTM Avg
-4.96%
3Y Avg
-2.45%
5Y Avg
-3.32%
Market Cap
$68.76M
Return on Invested Capital (ROIC)
-10.85%
TTM Avg
-101.00%
3Y Avg
-120.85%
5Y Avg
-96.47%
Market Cap
$68.77M
Return on Invested Capital (ROIC)
-6.75%
TTM Avg
20.47%
3Y Avg
-36.30%
5Y Avg
-23.36%
| NAME | MARKET CAP | RETURN ON INVESTED CAPITAL (ROIC) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Cingulate Inc. (CING) | $65.86M | -83.74% | -154.01% | -328.86% | -200.96% |
| Gossamer Bio, Inc. (GOSS)vs › | $66.42M | N/A | -86.10% | -83.22% | -74.34% |
| Heron Therapeutics, Inc. (HRTX)vs › | $63.79M | -6.79% | -4.87% | -47.70% | -62.00% |
| Pliant Therapeutics, Inc. (PLRX)vs › | $63.78M | -56.22% | -67.31% | -52.91% | -45.67% |
| Alps Group Inc (ALPS)vs › | $63.23M | N/A | -165.22% | -160.52% | -107.11% |
| Kalaris Therapeutics Inc (KLRS)vs › | $63.30M | -52.40% | -44.92% | -44.92% | -44.02% |
| InterCure Ltd. (INCR)vs › | $63.14M | -4.72% | -4.96% | -2.45% | -3.32% |
| Fortress Biotech, Inc. (FBIO)vs › | $68.76M | -10.85% | -101.00% | -120.85% | -96.47% |
| Champions Oncology, Inc. (CSBR)vs › | $68.77M | -6.75% | 20.47% | -36.30% | -23.36% |
| iBio, Inc. (IBIO)vs › | $70.21M | -40.22% | -72.23% | -74.75% | -58.95% |
ROIC
-83.7%
ROE
-122.7%
ROIC = NOPAT / Invested Capital, where NOPAT = Operating Income × (1 − effective tax rate) and Invested Capital = Total Assets − (Current Liabilities − Short-Term Debt)
Return on invested capital measures the after-tax operating return a company earns on the capital invested in the business. TGMCharts computes it from reported statements: trailing-twelve-month operating income after tax, over invested capital at the latest balance sheet — total assets less the non-interest-bearing current liabilities (payables, accruals, deferred revenue) that fund them; short-term debt stays in the capital base. The tax rate is the period's own effective rate (income tax ÷ pretax income), capped at 45%; when pretax income is zero or negative, or the tax line is a net benefit, no tax is deducted — the operating figure is shown untaxed rather than adjusted by an assumed rate. Not shown for banks, insurers or funds.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON INVESTED CAPITAL (ROIC) |
|---|---|
| 2026-06-30 | -83.74% |
| 2026-03-31 | -92.74% |
| 2025-12-31 | -180.33% |
| 2025-09-30 | -262.87% |
| 2025-06-30 | -150.35% |
| 2025-03-31 | -149.40% |
| 2024-12-31 | -125.97% |
| 2024-09-30 | -134.86% |
| 2024-06-30 | -606.44% |
| 2024-03-31 | -672.69% |
| 2023-09-30 | -651.31% |
| 2023-06-30 | -835.63% |
| 2023-03-31 | -296.89% |
| 2022-12-31 | -186.34% |
| 2022-09-30 | -112.19% |
| 2022-06-30 | -209.50% |
| 2022-03-31 | -144.98% |
| 2021-12-31 | -95.25% |
| 2021-09-30 | -439.44% |
| 2021-06-30 | -145.10% |
| 2020-12-31 | -242.05% |
